000 01374 a2200385 4500
005 20250516093918.0
264 0 _c20121012
008 201210s 0 0 eng d
022 _a1687-5303
024 7 _a10.1155/2012/216512
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLi, Bing
245 0 0 _aPrevention of diabetic complications by activation of Nrf2: diabetic cardiomyopathy and nephropathy.
_h[electronic resource]
260 _bExperimental diabetes research
_c2012
300 _a216512 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aAntioxidants
_xmetabolism
650 0 4 _aDiabetes Complications
_xprevention & control
650 0 4 _aDiabetic Cardiomyopathies
_xprevention & control
650 0 4 _aDiabetic Nephropathies
_xprevention & control
650 0 4 _aGene Expression Regulation
650 0 4 _aHumans
650 0 4 _aInflammation
650 0 4 _aMice
650 0 4 _aModels, Biological
650 0 4 _aNF-E2-Related Factor 2
_xmetabolism
650 0 4 _aOxidative Stress
650 0 4 _aReactive Oxygen Species
700 1 _aLiu, Shujun
700 1 _aMiao, Lining
700 1 _aCai, Lu
773 0 _tExperimental diabetes research
_gvol. 2012
_gp. 216512
856 4 0 _uhttps://doi.org/10.1155/2012/216512
_zAvailable from publisher's website
999 _c21821113
_d21821113